physostigmine salicylate has been researched along with scopolamine hydrobromide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Field, MJ; Iversen, SD; Rupniak, NM; Samson, NA; Tye, SJ | 1 |
| Ganguly, DK; Mitra, N; Mohanakumar, KP | 1 |
| Aggleton, JP; Aigner, TG; DeLong, MR; Mishkin, M; Mitchell, SJ; Price, DL; Struble, RG; Wenk, GL | 1 |
| King, GA | 1 |
| ROZSA, P | 1 |
| Khakpai, F; Nasehi, M; Yousefi, B; Zarrindast, MR | 1 |
7 other study(ies) available for physostigmine salicylate and scopolamine hydrobromide
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Evidence against a specific effect of cholinergic drugs on spatial memory in primates.
Topics: Animals; Attention; Brain; Dose-Response Relationship, Drug; Female; Macaca mulatta; Male; Mental Recall; Orientation; Physostigmine; Psychomotor Performance; Receptors, Cholinergic; Retention, Psychology; Scopolamine; Space Perception | 1991 |
Tremorogenesis by physostigmine is unrelated to acetylcholinesterase inhibition: evidence for serotoninergic involvement.
Topics: Acetylcholinesterase; Animals; Atropine; Caudate Nucleus; Cyproheptadine; Mecamylamine; Mesencephalon; Methysergide; Mice; Mice, Inbred BALB C; Physostigmine; Putamen; Scopolamine; Serotonin; Tremor | 1990 |
Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert.
Topics: Acetylcholinesterase; Animals; Basal Ganglia; Brain Mapping; Choline O-Acetyltransferase; Cholinergic Fibers; Discrimination Learning; Dose-Response Relationship, Drug; Form Perception; Ibotenic Acid; Macaca fascicularis; Oxazoles; Pattern Recognition, Visual; Physostigmine; Receptors, Muscarinic; Scopolamine; Substantia Innominata | 1987 |
Protective effects of vinpocetine and structurally related drugs on the lethal consequences of hypoxia in mice.
Topics: Alkaloids; Animals; Body Temperature; Hypoxia; Male; Mice; Mice, Inbred Strains; Physostigmine; Scopolamine; Vasodilator Agents; Vinca Alkaloids; Vincamine | 1987 |
[A NEW METHOD FOR THE DETERMINATION OF PHYSOSTIGMINE SALICYLATE, SCOPOLAMINE BROMIDE AND ATROPINE BASE].
Topics: Atropine; Bromides; Chemistry Techniques, Analytical; Physostigmine; Research; Salicylates; Scopolamine | 1965 |
Possible interaction of cholinergic and GABAergic systems between MS and CA1 upon memory acquisition in rats.
Topics: Analysis of Variance; Animals; Avoidance Learning; Bicuculline; CA1 Region, Hippocampal; Cholinergic Agents; Cholinergic Antagonists; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Male; Memory; Mental Recall; Motor Activity; Muscimol; Neural Pathways; Physostigmine; Rats; Rats, Wistar; Reaction Time; Scopolamine; Septum of Brain | 2012 |